MiR-499-5p contributes to hepatic insulin resistance by suppressing PTEN

Cellular Physiology and Biochemistry

Volumn 36, Issue 6, 2015, Pages 2357-2365

  Wang, Lei ^a   Zhang, Ning ^b   Pan, Hua Ping ^c   Wang, Zun ^a   Cao, Zhen Yu ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Insulin resistance; MiR 499 5p; PTEN; Type 2 diabetes

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; LUCIFERASE; MICRORNA; MICRORNA 499 5P; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; MIRN499 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME REPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE TOLERANCE; GLYCOGEN ANALYSIS; GLYCOGEN SYNTHESIS; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TISSUE LEVEL; UPREGULATION; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CELL LINE; DNA MICROARRAY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LIVER; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADENOVIRIDAE; ANIMALIA; MUS;

ANIMALS; BASE SEQUENCE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GLYCOGEN SYNTHASE KINASE 3; INSULIN RESISTANCE; LIVER; MALE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84939617060     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430198     Document Type: Article

References (22)

1. McCarthy MI: Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339-2350.
2. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116:151-157.
3. Dong Y, Gao G, Fan H, Li S, Li X, Liu W: Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway. PLoS One. 2015;10:e0124778.
4. Peyrou M, Bourgoin L, Foti M: PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer. Dig Dis 2010;28:236-246.
5. Vinciguerra M, Foti M: PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signaling. Arch Physiol Biochem 2006;112:89-104.
6. Hodakoski C, Hopkins BD, Barrows D, Mense SM, Keniry M, Anderson KE, Kern PA, Hawkins PT, Stephens LR, Parsons R: Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis. Proc Natl Acad Sci U S A 2014;111:155-160.
7. Ye EA, Steinle JJ: miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation 2015;12:44.
8. Wang R, Hong J, Cao Y, Shi J, Gu W, Ning G, Zhang Y, Wang W: Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults. Eur J Endocrinol 2015;172:291-300.
9. de Guia RM, Rose AJ, Sommerfeld A, Seibert O, Strzoda D, Zota A, Feuchter Y, Krones-Herzig A, Sijmonsma T, Kirilov M, Sticht C, Gretz N, Dallinga-Thie G, Diederichs S, Klöting N, Blher M, Berriel Diaz M, Herzig S: microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis. EMBO J 2015;34:344-360.
10. Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF: Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. Cell Physiol Biochem 2014;34:1983-1997.
11. Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y: MicroRNA-499-5p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol 2015;8:337-344.
12. Jacovetti C, Jimenez V, Ayuso E, Laybutt R, Peyot ML, Prentki M, Bosch F, Regazzi R: Contribution of intronic miR-499-5p and its Hosting Gene AATK to Compensatory β-cell Mass Expansion. Mol Endocrinol 2015;29:693-702.
13. Guay C, Regazzi R: Role of islet microRNAs in diabetes: which model for which question? Diabetologia 2015;58:456-463.
14. Chakraborty C, Doss CG, Bandyopadhyay S, Agoramoorthy G: Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes. Wiley Interdiscip Rev RNA 2014;5:697-712.
15. Kurtz CL, Peck BC, Fannin EE, Beysen C, Miao J, Landstreet SR, Ding S, Turaga V, Lund PK, Turner S, Biddinger SB, Vickers KC, Sethupathy P: MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes 2014;63:3141-3148.
16. Peyrou M, Bourgoin L, Poher AL, Altirriba J, Maeder C, Caillon A, Fournier M, Montet X, Rohner-Jeanrenaud F, Foti M: Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. J Hepatol 2015;62:421-429.
17. Yuan J, Benway CJ, Bagley J, Iacomini J: MicroRNA-494 Promotes Cyclosporine-Induced Nephrotoxicity and Epithelial to Mesenchymal Transition by Inhibiting PTEN. Am J Transplant 2015;15:1682-1691
18. Zhu H, Han C, Lu D, Wu T: miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. Am J Pathol 2014;184:2828-2839.
19. Zhang L, Chen X, Su T, Li H, Huang Q, Wu D, Yang C, Han Z: Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis 2015;7:303-308.
20. Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, Ma K, Zhang Y, Li X, Zhou C: miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol 2014;11:339-350.
21. Baranowski M, Zabielski P, Błachnio-Zabielska AU, Harasim E, Chabowski A, Grski J: Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation. Cell Physiol Biochem 2014;33:1047-1057.
22. Catherine P, Jean G: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2013;118:829-838.